https://www.mynewsdesk.com/se/unimedic-pharma Mynewsdesk RSS - pressmeddelanden, nyheter och blogginlägg. https://www.mynewsdesk.com/se/unimedic-pharma https://www.mynewsdesk.com/assets/graphics/logos/logo-small-9892f98564f91864075bd14001f8470f2f9bf254729c37044b4b1ac9b0db6b40.png 128 23 sv 15 Mon, 13 Oct 2025 16:54:03 +0200 Unimedic Pharma launches Melatonin oral solution – prescription-free option for adults experiencing jet lag. This product offers flexible dosing tailored to individual needs and is particularly suitable for those who find swallowing tablets challenging. Its compact bottle also makes it ideal for travel across multiple time zones. https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-launches-melatonin-oral-solution-prescription-free-option-for-adults-experiencing-jet-lag-3410224?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-launches-melatonin-oral-solution-prescription-free-option-for-adults-experiencing-jet-lag-3410224?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Fri, 03 Oct 2025 14:42:25 +0200 Unimedic Pharma lanserar Melatonin oral lösning – receptfritt alternativ för vuxna vid jetlag. Produkten erbjuder flexibel dosering som kan anpassas efter individuella behov och är särskilt lämplig för personer som har svårt att svälja tabletter. Den lilla flaskan gör den enkel att ta med på resor över flera tidszoner. Säljs på apotek fr.o.m. vecka 41. https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-lanserar-melatonin-oral-loesning-receptfritt-alternativ-foer-vuxna-vid-jetlag-3405729?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-lanserar-melatonin-oral-loesning-receptfritt-alternativ-foer-vuxna-vid-jetlag-3405729?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Mon, 21 Jul 2025 14:00:00 +0200 https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-acquires-xgx-pharma-3397210?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-acquires-xgx-pharma-3397210?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Mon, 02 Jun 2025 09:00:00 +0200 https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/melatonin-unimedic-pharma-1-mg-slash-ml-drink-for-children-with-adhd-and-insomnia-now-available-in-the-belgian-market-3389165?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/melatonin-unimedic-pharma-1-mg-slash-ml-drink-for-children-with-adhd-and-insomnia-now-available-in-the-belgian-market-3389165?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Tue, 17 Sep 2024 13:09:02 +0200 https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-announces-distribution-and-launch-of-zeqmelit-r-orodispersible-film-dexametason-in-sweden-norway-and-finland-3343256?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-announces-distribution-and-launch-of-zeqmelit-r-orodispersible-film-dexametason-in-sweden-norway-and-finland-3343256?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Wed, 20 Dec 2023 08:51:28 +0100 https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-out-license-melatonin-oral-solution-in-belgium-to-twinpharma-bv-3294204?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-out-license-melatonin-oral-solution-in-belgium-to-twinpharma-bv-3294204?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Thu, 31 Aug 2023 17:30:00 +0200 Stockholm, August 31st, 2023 – Unimedic Pharma AB announced today that Unimedic Pharma has entered into a license and distribution agreement with AcuCort AB for AcuCort’s Zeqmelit® oral film (dexametason) in Sweden, Denmark, Norway, and Finland. https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-announces-new-distribution-agreement-with-acucort-for-zeqmelit-r-oral-film-dexametason-in-sweden-denmark-norway-and-finland-3270236?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-announces-new-distribution-agreement-with-acucort-for-zeqmelit-r-oral-film-dexametason-in-sweden-denmark-norway-and-finland-3270236?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Tue, 01 Feb 2022 08:00:00 +0100 Unimedic Pharma AB have signed a license and supply agreement with Consilient Health for the launch of Melatonin 1 mg/ml oral solution in the UK. On November 16, 2021 the Medicines and Healthcare products Regulatory Agency (MHRA) granted Melatonin Consilient Health approval for insomnia in children with ADHD, as well as for short-term jet-lag therapy in adults https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-enter-a-collaboration-with-consilient-health-limited-for-the-launch-of-melatonin-oral-solution-in-the-uk-3159226?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-enter-a-collaboration-with-consilient-health-limited-for-the-launch-of-melatonin-oral-solution-in-the-uk-3159226?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Thu, 01 Jul 2021 08:00:00 +0200 Melatonin Unimedic Pharma erhåller subvention i Sverige och Norge. Det är den första och enda registrerade orala beredningen innehållandes melatonin på dessa marknader som subventioneras för barn och ungdomar med adhd där sömnhygienåtgärder är otillräckliga. https://www.mynewsdesk.com/se/unimedic-pharma/news/melatonin-unimedic-pharma-loesning-erhaaller-subvention-i-sverige-och-norge-441076?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/melatonin-unimedic-pharma-loesning-erhaaller-subvention-i-sverige-och-norge-441076?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Sat, 08 May 2021 08:00:00 +0200 Läkemedelsverket har idag meddelat att man godkänt Mollisupradin för behandling av hosta med segt slem och samtidigt behov av bronkvidgande effekt. Beslutet gäller från och med 8 maj 2020. https://www.mynewsdesk.com/se/unimedic-pharma/news/laekemedelsverket-godkaennner-mollisupradin-ett-generiskt-alternativ-till-mollipect-441712?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/laekemedelsverket-godkaennner-mollisupradin-ett-generiskt-alternativ-till-mollipect-441712?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Thu, 31 May 2018 08:00:00 +0200 Läkemedelsverket har idag meddelat att man godkänt Efedrin Unimedic 5 mg/ml injektionsvätska som ett registrerat läkemedel i Sverige. Beslutet gäller från och med 29 maj 2018. https://www.mynewsdesk.com/se/unimedic-pharma/news/laekemedelsverket-godkaenner-efedrin-unimedic-som-ett-registrerat-laekemedel-i-sverige-441748?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/laekemedelsverket-godkaenner-efedrin-unimedic-som-ett-registrerat-laekemedel-i-sverige-441748?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Tue, 20 Sep 2016 08:00:00 +0200 Stockholm, September, 20th 2016 – Unimedic Pharma AB announced today that Unimedic has entered into a licence and distribution agreement with Basilea Pharmaceutica Ltd. (SIX: BSLN) for Basilea’s antifungal CRESEMBA® (isavuconazole) and antibiotic Zevtera® (ceftobiprole) in the Nordic countries, including Sweden, Denmark, Norway and Finland. https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-announces-new-distribution-agreement-with-basilea-for-cresemba-r-isavuconazole-and-zevtera-r-ceftobiprole-in-the-nordic-countries-1565557?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-announces-new-distribution-agreement-with-basilea-for-cresemba-r-isavuconazole-and-zevtera-r-ceftobiprole-in-the-nordic-countries-1565557?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Thu, 30 Jun 2016 10:30:00 +0200 Unimedic Pharma, the Sweden based specialty pharma company today announced a new agreement with its strategic partner Martindale Pharma for its Emergency/Intensive Care sterile ampoule products in Sweden, Denmark, Norway and Finland. The products will be available in the end of 2017 or beginning of 2018. https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-pharma-r-announces-extension-of-licensing-agreement-with-martindale-pharma-to-include-emergency-care-product-portfolio-172063?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-pharma-r-announces-extension-of-licensing-agreement-with-martindale-pharma-to-include-emergency-care-product-portfolio-172063?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Fri, 17 Jun 2016 15:06:00 +0200 Altia Plc och Unimedic AB har slutit ett långsiktigt avtal avseende tillverkning av svensk akvavit och kryddat brännvin. Altia och Unimedic investerar gemensamt i ny produktionsutrustning och en ny produktionsanläggning. Produktionsprocessen inkluderar kryddestillation, kryddextraktion, blandning och lagring av svensk akvavit och kryddat brännvin. Destilleriet byggs i Matfors, Sundsvall. https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-och-altia-startar-produktion-av-svensk-akvavit-och-kryddat-braennvin-i-sundsvall-1444535?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-och-altia-startar-produktion-av-svensk-akvavit-och-kryddat-braennvin-i-sundsvall-1444535?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Tue, 07 Jun 2016 13:21:30 +0200 ​Unimedic har kommit överens med Stada Nordic (PharmaCoDane) att ta över ansvaret för Neostigmin® från och med den 1 juni 2016. Neostigmin är en viktig produkt för en mindre grupp patienter där det finns behov att reversera icke depolariserande muskelrelaxantia (återfå normal muskelfunktion). Den fulla indikationen är tarm- och blåsatoni. Myasthenia gravis. https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-har-tagit-oever-ansvaret-att-producera-och-tillhandahaalla-neostigmin-r-fraan-den-1-juni-syftet-bakom-oevertagandet-aer-att-saekerstaella-att-167983?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-har-tagit-oever-ansvaret-att-producera-och-tillhandahaalla-neostigmin-r-fraan-den-1-juni-syftet-bakom-oevertagandet-aer-att-saekerstaella-att-167983?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Tue, 17 May 2016 16:26:54 +0200 Unimedic Pharma AB lanserar nu NoPoxivir®, det enda medlet mot mollusker. Väl tolererat, effektivt och med kliniskt bevisad snabb effekt. NoPoxivir® är den enda produkten i Norden som har en indikation mot mollusker och detta är unikt. NoPoxivir finns nu receptfritt på samtliga apotekskedjor. https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-lanserar-en-fungerande-behandling-mot-mollusker-1407660?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/pressreleases/unimedic-pharma-ab-lanserar-en-fungerande-behandling-mot-mollusker-1407660?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Fri, 18 Dec 2015 16:42:00 +0100 Unimedic har träffat utlicensieringsavtal med Schweiziska företaget Sintetica avseende rättigheterna till Unimedics Fenylefrin file i marknaderna Tyskland, Österrike och Schweiz samt med det Brittiska företaget Martindale Pharma i marknaderna Storbritannien och GCC. Unimedic erhåller, som en del av avtalen, en engångsbetalning om 1,0 MSEK under verksamhetsåret 2015/2016 och 0,4 MSEK 2016/2017. https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-utlicensierar-fenylefrin-utanfoer-norden-162665?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-utlicensierar-fenylefrin-utanfoer-norden-162665?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Tue, 13 Oct 2015 14:42:00 +0200 Vi är glada att ha kunnat sluta ett långsiktigt samarbetsavtal från den 1 augusti 2015 med det tyska bolaget Infectopharm för deras pediatrikproduktportfölj och kommer ​att sälja och distribuera produkterna i samtliga nordiska länder”, säger Christer Ahlberg VD för Unimedic Pharma AB. https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-pharma-har-tecknat-ett-strategiskt-samarbetsavtal-med-det-tyska-bolaget-infectopharm-foer-den-nordiska-marknaden-161008?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-pharma-har-tecknat-ett-strategiskt-samarbetsavtal-med-det-tyska-bolaget-infectopharm-foer-den-nordiska-marknaden-161008?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Fri, 27 Mar 2015 15:17:00 +0100 Unimedic Pharma har utvecklat ett nytt läkemedel Fenylefrin Unimedic som nu har godkänts av Läkemedelsverket i Sverige. Produkten har tidigare varit ett extemporeläkemedel. https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-pharmas-produkt-fenylefrin-unimedic-aer-nu-godkaent-som-laekemedel-av-laekemedelsverket-i-sverige-161020?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-pharmas-produkt-fenylefrin-unimedic-aer-nu-godkaent-som-laekemedel-av-laekemedelsverket-i-sverige-161020?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma Thu, 01 Jan 2015 15:33:00 +0100 Unimedic Pharma AB har tecknat ett strategiskt avtal med Martindale Pharmaceuticals Ltd om att sälja, marknadsföra och distribuera Martindales akut- och sjukhusmedicinsortiment i Sverige. https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-tecknar-strategiskt-samarbetsavtal-med-martindale-pharma-foer-deras-akut-och-sjukhusprodukter-i-sverige-161024?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/unimedic-pharma/news/unimedic-tecknar-strategiskt-samarbetsavtal-med-martindale-pharma-foer-deras-akut-och-sjukhusprodukter-i-sverige-161024?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Unimedic Pharma